The Cybersecurity and Infrastructure Security Agency is tracking an unknown malicious cyber actor who is spoofing the Small Business Administration COVID-19 loan relief webpage via phishing emails, the agency announced yesterday.

Sent to various recipients in the Federal Civilian Executive Branch and state, local, tribal and territorial government, the emails include a malicious link to the spoofed SBA website that the cyber actor is using for malicious re-directs and credential stealing, the agency said.

For details, including recommended mitigation actions and other resources, see the .

鈥淎s we can see, heinous COVID-19-themed fraud schemes continue to perpetuate, and the common denominator seems to be enticing unsuspecting victims to provide funds, passwords or personal identifying information,鈥 said John Riggi, AHA senior advisor for cybersecurity and risk. 鈥淭o mitigate these threats, educate staff, always independently verify solicitations (even from 鈥榯rusted鈥 sources), never provide down payments for PPE without verification and reputable references, and be suspect of any solicitations that claim to be affiliated with a government agency.鈥欌

Related News Articles

Headline
The FBI, Cybersecurity and Infrastructure Security Agency and Australian Cyber Security Centre June 4 released an advisory on updated actions and tactics used鈥
Headline
The National Security Agency, Cybersecurity and Infrastructure Security Agency and international partners May 22 released guidance on securing data used for鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
The FBI, along with the National Security Agency and other international cybersecurity agencies, this week released a joint agency advisory on cyber operations鈥
Headline
The FBI's Internet Crime Complaint Center released an alert May 7 warning of cyber actors exploiting vulnerabilities in end-of-life routers. Routers dated 2010鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥